Evaluation of the auxological and metabolic status in prepubertal children born small for gestational age

Journal of Pediatric Endocrinology and Metabolism

Volumn 18, Issue 7, 2005, Pages 677-688

  Toumba, Meropi ^a   Hadjidemetriou, Andreas ^a   Topouzi, Maria ^a   Savva, Savvas C ^a   Demetriadou, Rena ^b   Kanaris, Constantinos ^a   Skordis, Nicos ^a  

^a Archbishop Makarios III Hospital   (Cyprus)

^b NICOSIA GENERAL HOSPITAL   (Cyprus)

Author keywords

Growth; Insulin resistance; Intrauterine growth retardation; Small for gestational age

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CATCH UP GROWTH; CHILD; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; INSULIN RESISTANCE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; METABOLIC BALANCE; METABOLIC PARAMETERS; POSTNATAL GROWTH; PREMATURITY; PREPUBERTY; SMALL FOR DATE INFANT; VERY LOW BIRTH WEIGHT;

EID: 23644431750     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2005.18.7.677     Document Type: Article

References (47)

1. Bernstein PS, Divon MY. Etiologies of fetal growth restriction. Clin Obst Gynecol 1997; 40: 723-729.
2. Pollack RN, Divon MY. Intrauterine growth retardation: definition, classification, and etiology. Clin Obst Gynecol 1992; 35: 99-107.
3. Wallman HA. Intrauterine growth restriction: definition and etiology. Horm Res 1998; 49 (Suppl 2): 1-6.
4. Economides DL, Nicolaides KH, Cambell S. Metabolic and endocrine findings in appropriate and small for gestational age fetuses. J Perinat Med 1991; 19: 97-105.
5. Keller C, Keller KR, Shew SB, Plon SE. Growth deficiency and malnutrition in Blood syndrome. J Pediatr 1999; 134: 472-479.
6. Leperq J, Mathieu-Caputo D. Diagnosis and management of intrauterine growth retardation. Horm Res 1998; 49 (Suppl 2): 14-19.
7. Jensen RB, Clellakooty M, Vielwerth S, Vaag A, Larsen T, Greisen G, Skakkebaek NE, Scheike T, Juul A. Intrauterine growth retardation and consequences for endocrine and cardiovascular disease in adult life: Does insulin-like growth factor-I play a role? Horm Res 2003; 60 (Suppl 3): 136-148.
8. Lee P, Chernausek S, Hokken-Koelega A, Czernichow P. International Small for Gestational Age Advisory Board Consensus Development Conference Statement: Management of short children born small for gestational age, April 24-October 1, 2001. Pediatr 2003; 111: 1253-1261.
9. Albertson-Wikland K, Wennegren G, Wennegren M, Vilbergsson G, Rosberg S. Longitudinal follow-up of growth in children born small for gestational age. Acta Paediatr 1993; 82: 438-443.
10. Albertson-Wikland K, Karlberg J. Postnatal growth of children born small for gestational age. Acta Paediatr 1997; Suppl 423: 193-195.
11. Albertson-Wikland K, Boguszeski M, Karlberg J. Children born small for gestational age: postnatal growth and hormonal status. Horm Res 1998; 38: 733-739.
12. Barker DJP, Martyn CN, Osmond C, Hales CN, Fall CH. Growth in utero and serum cholesterol concentrations in adult life. Br Med J 1993; 207: 1524-1527.
13. Barker DJ, Hales CN, Fall CH, Osmond C, Philips K, Clark PM. Type 2 (non-insulin-dependant) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36: 62-67.
14. Raven G: Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
15. Tanner JM. Growth at Adolescence, 2nd Ed. Oxford: Blackwell Scientific, 1962.
16. Ogden C, Kuczmarsky R, Flegal K, Mei Z, Guo S, Wei R, Grummer-Starwn L, Curtin L, Roche A, Johnson C. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvement to the 1977 National Center for Health Statistics Version. Pediatrics 2000; 19: 45-142.
17. Voigt M, Schneider KTM, Jahrig K. German growth charts for premature babies. Frauenheilk 1996; 56: 550-558.
18. Reiter EO, Rosenfeld RG. Normal and aberrant growth. In: Wilson JD, Foster DW, Kronenmberg HM, Larsen PR. Williams Textbook of Endocrinology, 9th Ed. Philadelphia, PA: WB Saunders, 1998; 1427-1507.
19. Matthews DR, Hosker JP, Rudensky AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
20. Gibson A, Carney S, Wright N, Wales J. Measurement and the newborn infant. Horm Res 2003; 59 (Suppl 1): 119-128.
21. Albertson-Wikland K, Karlberg J. Natural growth in children born SGA with and without catch up growth. Horm Res 2003; 59 (Suppl 1): 129.
22. Karlberg J, Albertson-Wikland K. Growth in full term small for gestational age infants: from birth to final height. Pediatr Res 1995; 38: 733-739.
23. Elliman A, Bryan E, Walker J, Harvey D. The growth of low-birth-weight children. Acta Paediatr Scand 1992; 81: 311-314.
24. Cutfield W, Regan F, Jackson W, Jefferies C, Robinson E, Harris M, Hofman P. The endocrine consequences for very low birth weight premature infants. GH IGF Res 2004; 14: 130-134.
25. Kajantie E. Insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, phosphoisoforms of IGFBP-1 and postnatal growth in very-low-birth-weight infants. Horm Res 2003; 60 (Suppl 3): 124-130.
26. Ali O, Cohen P. Insulin-like growth factors and their binding proteins in children born small for gestational age: implication for growth hormone therapy. Horm Res 2003; 60 (Suppl 3): 115-123.
27. Leger J, Noel M, Limal JM, Czernichow P. Growth factors and intrauterine growth retardation. II. Serum growth hormone, insulin-like growth factor (IGFI), and IGF-binding protein 3 levels in children with intrauterine growth retardation compared with normal control subjects: prospective study from birth to two years of age. Pediatr Res 1996; 40: 101-107.
28. Gluckman PD. The endocrine regulation of fetal growth in late gestation. The role of insulin-like growth factors. J Clin Endocrinol Metab 1995; 80: 1047-1050.
29. Giudice LC, de Zegher F, Gargosky SE, Dsupin BA, Crystal RA, Hintz RL, Rosenfeld RG. Insulin-like growth factors and their binding proteins in the term and preterm fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 1995; 80: 1548-1555.
30. Thierot-Prevost G, Boccara JF, Francoual C, Badual J, Job C. Serum insulin-like growth factor 1 and serum growth-promoting activity during the first postnatal year in infants with intrauterine growth retardation. Pediatr Res 1988; 24: 380-383.
31. de Waal WJ, Hokken-Koelega AC, Stinjen TH, De Muinck Keizer Schrama SMPF, Drop SLS, and the Dutch Working Group on Growth Hormone. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. Clin Endocrinol 1994; 41: 621-630.
32. Boguszewski M, Jansson C, Rosberg S, Albertson-Wikland K. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age. J Clin Endocrinol Metab 1996; 81: 3902-3908.
33. Boguszewski M, Rosberg S, Albertson-Wikland K. Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children. J Clin Endocrinol Metab 1995; 80: 2599-2606.
34. Cohen P, Bright GM, Rogol AD, Kappelgaard AM, Rosenfield RG, for the American Norditropin Clinical Trials Group. Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety. J Clin Endocrinol Metab 2002; 87: 90-98.
35. Ozkan H, Aydin A, Demir N, Erci T, Buyukgebiz A. Associations of IGF-I, IGFBP-1 and IGFBP3 on intrauterine growth and early catch-up growth. Biol Neonate 1999; 76: 274-282.
36. Lithell HO, McKeigue PM, Berglund L, Mohsen R, Lithell UB, Leon DA. Relation of size at birth to non-insulin-dependent diabetes and insulin concentrations in men 50-60 years. Br Med J 1996; 312: 406-410.
37. Leger J, Levy-Marchal C, Bloch J, Pinet A, Chevanne D, Porquet D, Collin D, Czernichow P. Reduced final height and indications for insulin resistance in 20 year olds born small for gestational age: regional cohort study. Br Med J 1997; 315: 341-347.
38. Phillips DI, Barker DJ, Hales CN, Hirst S, Osmond C. Thinness at birth and insulin resistance in adult life. Diabetologia 1994; 37: 150-154.
39. Jaquet D, Gaboriau A, Czernichow P, Levy-Marshal C. Insulin resistance early in adulthood in subjects born with intra-uterine growth retardation. J Clin Endocrinol Metab 2000; 85: 1401-1406.
40. Valdez R, Athens MA, Thompson GH, Bradshaw BS, Stern MP. Birth weight and adult health outcomes in a biethnic population in the USA. Diabetologia 1994; 37: 624-631.
41. Goldman SL, Hirata T. Attenuated response to insulin in very low birthweight infants. Pediatr Res 1980; 14: 50-53.
42. Bazeas RA, Alegria A, Pittaluga E, Avila A, Iniguez G, Mericq V. Determinants of insulin sensitivity and secretion in very-low-birthweight children. J Clin Endocrinol Metab 2004; 89: 1267-1272.
43. Hofman L, Cutfield WS, Robinson EM, Bergman RN, Menon RK, Sperling MA, Gluckman PD. Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab 1997; 82: 402-406.
44. Chiarelli F, di Ricco L, Mohn A, De Martino M, Verrotti A. Insulin resistance in short children with intrauterine retardation. Acta Paediatr 1999; 88 (Suppl 428): 62-65.
45. Chatelain P. Children born with intrauterine growth retardation (IUGR) or small for gestational age (SGA): long term growth and metabolic consequences. Endocr Regul 2000; 34: 33-36.
46. Ibanez L, Potau N, Francois I, De Zegher F. Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 1998; 83: 3558-3562.
47. Ibanez L, Potau N, Francois I, de Zegher F. Precocious pubarche, dyslipidaemia, and low IGF binding protein 1 in girls: relation to reduced prenatal growth. Pediatr Res 1999; 46: 320-322.